ADPROTECH
DEAD

Serial Number

76183783

Owner

ADPROTECH LIMITED

Attorney

JOHN C WILSON

Filing Date

Dec 21, 2000

Add to watchlist:

No watchlists yet
View on USPTO

ADPROTECH Trademark

Serial Number: 76183783 • Registration: 2863973

ADPROTECH is a trademark filed by ADPROTECH LIMITED on December 21, 2000. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ADPROTECH LIMITED (2 trademarks)

The Maltings, Green Drift
Royston Harts SG8 5DY , GB

Entity Type: 11

Trademark Details

Filing Date

December 21, 2000

Registration Date

July 20, 2004

Published for Opposition

September 2, 2003

Cancellation Date

February 25, 2011

Goods & Services

Pharmaceutical preparations, protein therapeutic agents, prodrugs and polypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation; veterinary preparations, protein therapeutic agents, prodrugs and ploypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation, for use in domestic animals and livestock; immunotherapeutic agents for the treatment of autoimmune and inflammatory disorders, infectious diseases and cancer, for use in humans and domestic animals and livestock; vaccine molecular adjuvants

Medical and veterinary apparatus and instruments, namely, depot devices for the delivery of drugs and vaccine adjuvants, syringes, and catheters; drug delivery systems consisting primarily of implant devices for the delivery of drugs and vaccine adjuvants, depot devices for the delivery of drugs and vaccine adjuvants, syringes, catheters, and vaccine adjuvants

Biotechnology product research and development; product development for others in the chemical, medical and veterinary fields; product research and development relating to modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvants; technical consultation services relating to biotechnology, modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvants

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 25, 2011 C8..
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2004 R.PR
NOTICE OF ALLOWANCE CANCELLED
Jun 4, 2004 IUCN
SOU EXTENSION 1 GRANTED
Jun 3, 2004 EX1G
CASE FILE IN TICRS
May 28, 2004 CFIT
Sec. 1(B) CLAIM DELETED
May 26, 2004 1.BD
PAPER RECEIVED
May 26, 2004 MAIL
SOU EXTENSION 1 FILED
May 24, 2004 EXT1
SOU TEAS EXTENSION RECEIVED
May 24, 2004 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 25, 2003 NOAM
PUBLISHED FOR OPPOSITION
Sep 2, 2003 PUBO
NOTICE OF PUBLICATION
Aug 13, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2003 CNSA
EXAMINERS AMENDMENT MAILED
May 15, 2003 CNEA
FINAL REFUSAL MAILED
Nov 19, 2002 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2002 TCCA
PAPER RECEIVED
Jul 12, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2002 CRFA
LETTER OF SUSPENSION MAILED
Jan 11, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2001 CRFA
NON-FINAL ACTION MAILED
Apr 19, 2001 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2001 DOCK